Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patient survival was no different for living donor liver transplant recipients with a MELD score ...
Aim: To predict prognosis in patients with acute-on-chronic hepatitis (AOCH) using the model for end-stage liver disease (MELD) scoring system and to study the effects of age, sex, etiology, low serum ...
Please provide your email address to receive an email when new articles are posted on . On-treatment improvement of MELD scores correlated with reduced risk for all-cause mortality and hepatic events ...
Liver transplant candidates may get a fairer shake from an artificial intelligence-based organ allocation system than that offered by the current Model for End-Stage Liver Disease (MELD) scoring ...
A low MELD score can limit access to high-priority deceased-donor allocation, making living donor liver transplantation a ...
The Model for End-stage Liver Disease (MELD) score—derived from serum total bilirubin and creatinine levels, plus the international normalized ratio—is commonly used in the US to assess patients' ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Laboratory ...
Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...
Using data derived from all adult candidates for primary liver transplantation who were registered with the Organ Procurement and Transplantation Network in 2005 and 2006, we developed and validated a ...
Prognostic scores are valuable tools for predicting survival in patients with chronic liver disease. Recently, the albumin-bilirubin (ALBI) score has emerged as a potential prognostic indicator in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results